These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
95 related items for PubMed ID: 2183566
21. Immunoadjuvanticity of endotoxins and nontoxic derivatives for normal and leukemic immunocytes. Friedman H, Klein T, Specter S, Newton C, Nowotny A. Adv Exp Med Biol; 1990; 256():525-35. PubMed ID: 2183563 [Abstract] [Full Text] [Related]
22. Involvement of gamma interferon in antibody enhancement by adjuvants. Odean MJ, Frane CM, Van derVieren M, Tomai MA, Johnson AG. Infect Immun; 1990 Feb; 58(2):427-32. PubMed ID: 2105274 [Abstract] [Full Text] [Related]
23. Monophosphoryl lipid A (MPL) upregulates major histocompatibility complex (MHC) class I expression by increasing interferon-gamma (IFN-gamma). Cho CH, Lee BK, Kwak SM, Kim JD. Yonsei Med J; 1999 Feb; 40(1):20-5. PubMed ID: 10198602 [Abstract] [Full Text] [Related]
25. Stimulation of B-immunocytes by a T-cell factor produced in mixed leukocyte cultures. Friedman H. Ann N Y Acad Sci; 1975 Feb 28; 249():264-77. PubMed ID: 124153 [No Abstract] [Full Text] [Related]
26. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses. Schiött A, Larsson K, Manniche S, Kalliomäki S, Heydenreich AV, Dalsgaard K, Kirkby N. Int J Pharm; 2011 Jul 29; 414(1-2):312-20. PubMed ID: 21601626 [Abstract] [Full Text] [Related]
27. Functional characteristics of Peyer's patch lymphoid cells. II. Lipopolysaccharide is thymus dependent. Kagnoff MF, Billings P, Cohn M. J Exp Med; 1974 Feb 01; 139(2):407-13. PubMed ID: 4589992 [Abstract] [Full Text] [Related]
28. Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination. Leroux-Roels G, Van Belle P, Vandepapeliere P, Horsmans Y, Janssens M, Carletti I, Garçon N, Wettendorff M, Van Mechelen M. Vaccine; 2015 Feb 18; 33(8):1084-91. PubMed ID: 25444781 [Abstract] [Full Text] [Related]
29. Mode of action of a supernatant activity from T-cell cultures that nonspecifically stimulates the humoral immune response. Hunter P, Kettman JR. Proc Natl Acad Sci U S A; 1974 Feb 18; 71(2):512-6. PubMed ID: 4273650 [Abstract] [Full Text] [Related]
30. Ability of monophosphoryl lipid A to augment the antibody response of young mice. Baker PJ, Hiernaux JR, Fauntleroy MB, Stashak PW, Prescott B, Cantrell JL, Rudbach JA. Infect Immun; 1988 Dec 18; 56(12):3064-6. PubMed ID: 2972626 [Abstract] [Full Text] [Related]
31. Cellular requirements for the primary in vitro antibody response to DNP-ficoll. Mosier DE, Johnson BM, Paul WE, McMaster PR. J Exp Med; 1974 May 01; 139(5):1354-60. PubMed ID: 4596514 [Abstract] [Full Text] [Related]
32. A Th1-inducing adjuvant, MPL, enhances antibody profiles in experimental animals suggesting it has the potential to improve the efficacy of allergy vaccines. Wheeler AW, Marshall JS, Ulrich JT. Int Arch Allergy Immunol; 2001 Oct 01; 126(2):135-9. PubMed ID: 11729351 [Abstract] [Full Text] [Related]
33. Distinctive immunomodulatory effects of endotoxin and nontoxic lipopolysaccharide derivatives in lymphoid cell cultures. Friedman H, Blanchard DK, Newton C, Klein T, Stewart W, Keler T, Nowotny A. J Biol Response Mod; 1987 Dec 01; 6(6):664-77. PubMed ID: 2453617 [Abstract] [Full Text] [Related]
34. Roles of Aluminum Hydroxide and Monophosphoryl Lipid A Adjuvants in Overcoming CD4+ T Cell Deficiency To Induce Isotype-Switched IgG Antibody Responses and Protection by T-Dependent Influenza Vaccine. Ko EJ, Lee YT, Kim KH, Lee Y, Jung YJ, Kim MC, Lee YN, Kang T, Kang SM. J Immunol; 2017 Jan 01; 198(1):279-291. PubMed ID: 27881702 [Abstract] [Full Text] [Related]
35. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. Carozzi S, Salit M, Cantaluppi A, Nasini MG, Barocci S, Cantarella S, Lamperi S. J Clin Microbiol; 1989 Aug 01; 27(8):1748-53. PubMed ID: 2504774 [Abstract] [Full Text] [Related]
36. The xenogeneic effect. II. Requirement for unactivated murine T cells during restoration of immune responsiveness with xenogeneic reconstitution factor. Farrar JJ, Fuller-Bonar J. J Immunol; 1976 Jul 01; 117(1):274-82. PubMed ID: 778265 [Abstract] [Full Text] [Related]
37. The influence of monophosphoryl lipid A (MPL) on erythrocyte autoantibody formation. Hraba T, Baker PJ, Taylor CE, Fauntleroy MB, Stashak PW. Immunobiology; 1993 Dec 01; 189(5):448-56. PubMed ID: 8125521 [Abstract] [Full Text] [Related]
38. Evaluation of the adjuvant effect of agonists of toll-like receptor 4 and 7/8 in a vaccine against leishmaniasis in BALB/c mice. Rostamian M, Niknam HM. Mol Immunol; 2017 Nov 01; 91():202-208. PubMed ID: 28963929 [Abstract] [Full Text] [Related]
39. T cell-dependent mediator and B-cell clones. Lefkovits I, QUintáns J, Munro A, Waldmann H. Immunology; 1975 Jun 01; 28(6):1149-54. PubMed ID: 1093973 [Abstract] [Full Text] [Related]
40. Carrageenan stimulates the release of dialyzable helper factors. Evelegh MJ, Clark DA, McCandless EL. Immunol Lett; 1982 Nov 01; 5(5):247-52. PubMed ID: 6761265 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]